Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE4
Combination of Rituximab and NK Immunotherapy for B Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
- Status
- COMPLETED
- Phase
- PHASE3
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 and Rituximab in Combination With CHOP, in Previously Untreated Subjects With CD20+ DLBCL
- Status
- COMPLETED
- Phase
- PHASE3
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
CyBeR Association in Relapsed/Refractory DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Chidamide Plus R-CHOP in Elderly DLBCL
- Status
- UNKNOWN
- Phase
- PHASE2
Reduced Chemotherapy in Low Risk DLBCL
- Status
- UNKNOWN
- Phase
- PHASE4
An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
- Status
- TERMINATED
- Phase
- PHASE4
Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab
- Status
- COMPLETED
- Phase
- PHASE3
RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.
- Status
- COMPLETED
- Phase
- PHASE3
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2